Healthcare provider profile · identity verified

Kristen Bourgon, MSN, AGPCNP-BC

Nurse Practitioner · SOUTHFIELD, MI · NPI 1851838809

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	461	55
Gabapentin	Gabapentin	297	46
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	240	24
Atorvastatin Calcium	Atorvastatin Calcium	236	65
Albuterol Sulfate Hfa	Albuterol Sulfate	175	45
Amlodipine Besylate	Amlodipine Besylate	145	43
Oxycodone Hcl	Oxycodone Hcl	133	15
Omeprazole	Omeprazole	122	28
Furosemide	Furosemide	115	42
Metoprolol Tartrate	Metoprolol Tartrate	115	28
Eliquis	Apixaban	112	23
Losartan Potassium	Losartan Potassium	109	24
Alprazolam	Alprazolam	102	13
Baclofen	Baclofen	92	14
Levothyroxine Sodium	Levothyroxine Sodium	90	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	86	15
Fluticasone Propionate	Fluticasone Propionate	86	30
Lisinopril	Lisinopril	85	24
Pantoprazole Sodium	Pantoprazole Sodium	85	30
Metoprolol Succinate	Metoprolol Succinate	80	23
Hydrochlorothiazide	Hydrochlorothiazide	77	19
Trazodone Hcl	Trazodone Hcl	77	19
Metformin Hcl	Metformin Hcl	74	23
Tamsulosin Hcl	Tamsulosin Hcl	74	16
Meloxicam	Meloxicam	73	18
Hydralazine Hcl	Hydralazine Hcl	68	21
Sertraline Hcl	Sertraline Hcl	68	17
Potassium Chloride	Potassium Chloride	67	16
Carvedilol	Carvedilol	66	26
Promethazine Hcl	Promethazine Hcl	63	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	61	11
Clopidogrel	Clopidogrel Bisulfate	59	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	18
Famotidine	Famotidine	55	suppressed
Ibuprofen	Ibuprofen	54	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	51	24
Tramadol Hcl	Tramadol Hcl	51	12
Donepezil Hcl	Donepezil Hcl	49	15
Tizanidine Hcl	Tizanidine Hcl	48	suppressed
Pregabalin	Pregabalin	47	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	46	11
Montelukast Sodium	Montelukast Sodium	44	suppressed
Nifedipine Er	Nifedipine	44	suppressed
Azithromycin	Azithromycin	42	31
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	11
Nystatin	Nystatin	42	16
Mirtazapine	Mirtazapine	41	suppressed
Ventolin Hfa	Albuterol Sulfate	39	12
Cephalexin	Cephalexin	36	22
Lorazepam	Lorazepam	35	suppressed
Simvastatin	Simvastatin	34	suppressed
Spironolactone	Spironolactone	34	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Clonazepam	Clonazepam	30	suppressed
Methocarbamol	Methocarbamol	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	12
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Diazepam	Diazepam	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	12
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Jardiance	Empagliflozin	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Hydrocortisone	Hydrocortisone	25	suppressed
Ammonium Lactate	Ammonium Lactate	24	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	23	suppressed
Lactulose	Lactulose	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	12
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Naproxen	Naproxen	21	suppressed
Temazepam	Temazepam	21	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	20	suppressed
Risperidone	Risperidone	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Ozempic	Semaglutide	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Fluconazole	Fluconazole	17	11
Olanzapine	Olanzapine	17	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Lacosamide	Lacosamide	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Otezla	Apremilast	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Atenolol	Atenolol	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Felbamate	Felbamate	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nateglinide	Nateglinide	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Prednisone	Prednisone	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error